Skip to main content

Part of the book series: Subcellular Biochemistry ((SCBI,volume 94))

Abstract

As normal constituents of blood serum, the Serum Amyloid A (SAA) proteins are small (104 amino acids in humans) and remarkably well-conserved in mammalian evolution. They are synthesized prominently, but not exclusively, in the liver. Fragments of SAA can associate into insoluble fibrils (called “amyloid”) characteristic of “secondary” amyloid disease in which they can interrupt normal physiology and lead to organ failure. SAA proteins comprise a family of molecules, two members of which (SAA1 and SAA2) are (along with C-reactive protein, CRP) the most prominent members of the acute phase response (APR) during which their serum levels rise dramatically after trauma, infection and other stimuli. Biologic function (s) of SAA are unresolved but features are consistent with a prominent role in primordial host defense (including the APR ). SAA proteins are lipophilic and contribute to high density lipoproteins (HDL) and cholesterol transport. SAA proteins interact with specific receptors and have been implicated in tissue remodeling through metalloproteinases, local tissue changes in atherosclerosis, cancer metastasis, lung inflammation, maternal–fetal health and intestinal physiology. Molecular details of some of these are emerging.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Aly H, Hamed Z, Mohsen L et al (2011) Serum amyloid A protein and hypoxic ischemic encephalopathy in the newborn. J Perinatol 31:263–268. https://doi.org/10.1038/jp.2010.130

    Article  CAS  PubMed  Google Scholar 

  • Atarashi K, Tanoue T, Ando M et al (2015) Th17 cell induction by adhesion of microbes to intestinal epithelial cells. Cell 163:367–380

    Google Scholar 

  • Benson MD, Buxbaum JN, Eisenberg DS et al (2019) Amyloid nomenclature 2018: recommendations by the International Society of Amyloidosis (ISA) nomenclature committee. Amyloid 5pp. https://doi.org/10.1080/13506129.2018.1549825

  • Bozinovski S, Hutchinson A, Thompson M et al (2008) Serum amyloid A is a biomarker of acute exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 177:269–278

    Article  CAS  Google Scholar 

  • Bozinovski S, Uddin M, Thompson M et al (2012) Serum amyloid A opposes lipoxin A4 to mediate glucocorticoid refractory lung inflammation in chronic obstructive pulmonary disease. Proc Natl Acad Sci 109:935–940

    Article  CAS  Google Scholar 

  • Brinckerhoff CE, Mitchell TI, Karmilowicz MJ et al (1989) Autocrine induction of collagenase by serum amyloid A-like and B2-microglobulin-like proteins. Science 243:655–657

    Article  CAS  Google Scholar 

  • Burgess EJ, Hoyt LR, Randall MJ et al (2018) Bacterial lipoproteins constitute the TLR-stimulating activity of serum amyloid A. J Immunol 201:2377–2384

    Article  CAS  Google Scholar 

  • Chen ES, Song Z, Willett MH et al (2010) Serum Amyloid A regulates granulomatous inflammation in sarcoidosis through toll-like receptor-2. Am J Respir Crit Care Med 181:360–373

    Article  CAS  Google Scholar 

  • Cheng N, Liang Y, Du X et al (2018) Serum amyloid A promotes LPS clearance and suppresses LPS-induced inflammation and tissue injury. EMBO Rep (e45517):14pp. https://doi.org/10.15252/embr.201745517

    Article  PubMed  PubMed Central  Google Scholar 

  • Claus S, Meinhardt K, Aumuller T et al (2017) Cellular mechanism of fibrila formation from serum amyloid A1 protein. EMBO Rep 18(8):1352–1366

    Article  CAS  Google Scholar 

  • Cohen AS, Calkins E (1959) Electron microscopic observations on a fibrous component in amyloid of diverse origins. Nature 183:1202–1203

    Google Scholar 

  • Connolly M, Marelli A, Blades M et al (2010) Acute serum amyloid A induces migration, angiogenesis, and inflammation in synovial cells in vitro and in a human rheumatoid arthritis/SCID mouse chimera model. J Immunol 184:6427–6437

    Article  CAS  Google Scholar 

  • Connolly M, Mullan RH, McCormick J et al (2012) Acute=phase serum amyloid A regulates tumor necrosis factor alpha and matric turnover and preficts disease progression in pastients with inflammatory arthritis before and after biologic therapy. Arthritis Rheum 64(4):1035–1045

    Article  CAS  Google Scholar 

  • De Buck M, Gouwy M, Wang JM et al (2016a) The cytokine-serum amyloid A-Chemokine network. Cytokine Growth Factor Rev 30:55–69

    Article  Google Scholar 

  • De Buck M, Gouwy M, Wang JM et al (2016b) Structure and expression of different serum amyloid A (SAA) variants and their concentration-dependent functions during host insults. Curr Med Chem 23:1725–1755

    Article  Google Scholar 

  • Hari-Dass R, Shah C, Meyer DJ et al (2005) Serum amyloid A proteins binds to outer membrane protein A of gram-negative bacteria. J Biol Chem 280(19):18562–18567

    Article  CAS  Google Scholar 

  • Ibrahim M, Ramy AR, Abdelhamid A et al (2017) Maternal serum amyloid A level as a novel marker of primary unexplained recurrent early pregnancy loss. Int J Gynecol Obstet 136:298–303

    Article  CAS  Google Scholar 

  • Ivanov II, Atarashi K, Manel N et al (2009) Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell 139:485–498

    Google Scholar 

  • King VL, Thompson J, Tannock LR (2011) Serum amyloid A in atherosclerosis. Curr Opin Lipidol 22:302–307

    Article  CAS  Google Scholar 

  • Kisilevsky R, Manley PN (2012) Acute-phase serum amyloid A: perspectives on its physiological and pathological roles. Amyloid 19(1):5–14

    Article  CAS  Google Scholar 

  • Knebel FH, Uno M, Galatro TF, Bellé LP, Oba-Shinjo SM, Marie SKN, Campa A (2017) Serum amyloid A1 is upregulated in human glioblastoma. J Neuro-Oncol 132(3):383–391

    Google Scholar 

  • Kushner I (1982) The phenomenon of the acute phase response. Ann N Y Acad Sci 39–48

    Google Scholar 

  • Landskron G, De La Fuente M, Thuwajit P et al (2014) Chronic inflammation and cytokines in the tumor microenvironment. J Immunol Res 2014:149185. https://doi.org/10.1155/2014/149185

  • Larson MA, Weber A, Weber AT et al (2005) Differential expression and secretion of bovine serum amyloid A3 (SAA3) by mammary epithelial cells stimulated with prolactin or lipopolysaccharide. Vet Immunol Immunopathol 107:255–264

    Article  CAS  Google Scholar 

  • Lee JW, Stone ML, Porrett PM et al (2019) Hepatocytes direct the formation of a pro-metastatic niche in the liver. Nature 567:249–252

    Google Scholar 

  • Linke RP, Meinel A, Chalcroft JP et al (2017) Serum amyloid A (SAA) treatment enhances the recovery of aggravated polymicrobial sepsis in mice, whereas blocking SAA's invariant peptide results in early death. Amyloid 24(S1):149–150

    Google Scholar 

  • Lu J, Yu Y, Zhu I et al (2014) Structural mechanism of serum amyloid A-mediated inflammatory amyloidosis. Proc Natl Acad Sci 111(14):5189–5194

    Article  CAS  Google Scholar 

  • Luhrs T, Ritter C, Adrian M et al (2005) 3D structure of Alzheimer's amyloid-β(1–42) fibrils. Proc Natl Acad Sci USA 102(48):17341–17347

    Article  Google Scholar 

  • Mack DR, McDonald TL, Larson MA et al (2003) The conserved TFLK motif of mammary-associated Serum Amyloid A3 is responsible for Up-regulation of intestinal MUC3 mucin expression in vitro. Pediatr Res 53(1):137–142

    Article  CAS  Google Scholar 

  • McDonald TL, Larson MA, Mack DR et al (2001) Elevated extrahepatic expression and secretion of mammary-associated serum amyloid A3 (M-SAA3) into colostrum. Vet Immunol Immunopathol 83:203–211

    Article  CAS  Google Scholar 

  • Meeker AK, Sack GH Jr (1998) A fusion protein between serum amyloid A and staphylococcal nuclease—synthesis, purification, and structural studies. Proteins Struct Funct Genet 30:381–387

    Google Scholar 

  • Mithal LB, Palac HL, Yogev R et al (2017) Cord blood acute phase reactants predict early onset neonatal sepsis in preterm infants. PLoS ONE 12(1):E0168677. https://doi.org/10.1371/journal.pone.0168677

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Morrow JF, Stearman RS, Peltzman CG et al (1981) Induction of hepatic synthesis of serum amyloid A protein and actin. Proc Natl Acad Sci USA 78:4718–4722

    Article  CAS  Google Scholar 

  • Moshkovskii SA (2012) Why do cancer cells produce serum amyloid A acute-phase protein? Biochemistry (Moscow) 77(4):339–341

    Article  CAS  Google Scholar 

  • Ridker PM, Everett BM, Thuren T et al (2017) Antiinflammatory therapy with Canakinumab for atherosclerotic disease. N Engl J Med 377(12):1119–1131

    Article  CAS  Google Scholar 

  • Sack GH Jr (2009) Amyloidosis (Chap. 46). In: Stone JH (ed) A clinician's pearls and myths in rheumatology. Springer, Dordrecht, pp 461–466

    Google Scholar 

  • Sack GH Jr (2018) Serum amyloid A - a review. Mol Med 24:46. https://doi.org/10.1186/s10020-10018-10047-10020

  • Sack GH Jr (2019) The pathophysiology of amyloid fibril formation. In: Amyloidosis. IntechOpen, London. https://doi.org/10.5772/intechopen.81965

  • Sack GH Jr, Zink MC (1992) Serum amyloid A (SAA) gene expression in synovial cells in retroviral arthritis. Am J Pathol 141:525–529

    Google Scholar 

  • Sack GH Jr, Zachara N, Rosenblum N et al (2018) Serum amyloid A1 (SAA1) protein in human colostrum. FEBS OpenBio 8:435–441. https://doi.org/10.1002/2211-5463.12383

  • Sano T, Huang W, Hall JA et al (2015) An IL-23/IL-22 circuit regulates epithelial serum amyloid A to promote local effector Th17 responses. Cell 163:381–393

    Google Scholar 

  • Shah C, Hari-Dass R, Raynes JG (2006) Serum amyloid A is an innate immune opsonin for Gram-negative bacteria. Blood 108:1751–1757

    Article  CAS  Google Scholar 

  • Sipe JD (1999) Revised nomenclature for serum Amyloid A (SAA). Nomenclature committee for the international society of amyloidosis. Part 1. Amyloid 6:67–70

    Article  CAS  Google Scholar 

  • Sun L, Ye RD (2016) Serum amyloid A1: structure, function and gene polymorphism. Gene 583:48–57

    Article  CAS  Google Scholar 

  • Yang Q, Whitin JC, Ling XB et al (2009) Plasma biomarkers in a mouse model of preterm labor. Pediatr Res 66(1):11–16

    Article  CAS  Google Scholar 

  • Ye RD, Sun L (2015) Emerging functions of serum amyloid A in inflammation. J Leukoc Biol 98(6):923–929

    Article  CAS  Google Scholar 

  • Zhou H, Chen M, Zhang G et al (2017) Suppression of lipopolysaccharide-induced inflammatory response by fragments from serum amyloid A. J Immunol 199:1105–1112

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to George H. Sack Jr. .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Sack, G.H. (2020). Serum Amyloid A (SAA) Proteins. In: Hoeger, U., Harris, J. (eds) Vertebrate and Invertebrate Respiratory Proteins, Lipoproteins and other Body Fluid Proteins. Subcellular Biochemistry, vol 94. Springer, Cham. https://doi.org/10.1007/978-3-030-41769-7_17

Download citation

Publish with us

Policies and ethics